Rheumatoid arthritis - PubMed (original) (raw)
. 2009 Feb 21;373(9664):659-72.
doi: 10.1016/S0140-6736(09)60008-8. Epub 2009 Jan 20.
Affiliations
- PMID: 19157532
- DOI: 10.1016/S0140-6736(09)60008-8
Rheumatoid arthritis
Lars Klareskog et al. Lancet. 2009.
Abstract
Rheumatoid arthritis is a systemic, inflammatory, autoimmune disorder. Enhanced understanding of molecular pathogenesis has enabled development of innovative biological agents that target specific parts of the immune system. These treatments have changed the course and face of rheumatoid arthritis and outcomes for patients and society. New knowledge has emerged of how environmental factors interact with susceptibility genes and the immune system in the pathogenesis of a major subset of rheumatoid arthritis. Research undertaken on the longitudinal disease process and molecular pathology of joint inflammation has led to new therapeutic strategies that promote early use of disease-modifying drugs with tight disease control and distinct and quantifiable treatment goals. Today, such approaches can halt most cases of joint destruction but not all instances of joint inflammation and comorbidity. Understanding the cause and pathogenesis of different rheumatoid arthritis subsets will lead not only to individualised treatments during early phases of the illness but also, possibly, to disease prevention.
Similar articles
- Rheumatoid arthritis.
Scott DL, Wolfe F, Huizinga TW. Scott DL, et al. Lancet. 2010 Sep 25;376(9746):1094-108. doi: 10.1016/S0140-6736(10)60826-4. Lancet. 2010. PMID: 20870100 Review. - [Proposal for biologic drugs therapy in rheumatoid arthritis].
Curković B, Babić-Naglić D, Morović-Vergles J, Anić B, Grazio S, Kaliterna DM, Hanih M, Novak S. Curković B, et al. Reumatizam. 2010;57(1):29-35. Reumatizam. 2010. PMID: 20941938 Croatian. - Tumor necrosis factor (TNF) inhibitor therapy for rheumatoid arthritis.
Segal B, Rhodus NL, Patel K. Segal B, et al. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008 Dec;106(6):778-87. doi: 10.1016/j.tripleo.2008.07.025. Epub 2008 Oct 19. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008. PMID: 18930662 Review. - Perioperative management of biologic agents used in treatment of rheumatoid arthritis.
Mushtaq S, Goodman SM, Scanzello CR. Mushtaq S, et al. Am J Ther. 2011 Sep;18(5):426-34. doi: 10.1097/MJT.0b013e3181cb4042. Am J Ther. 2011. PMID: 20216205 Review. - Management of rheumatoid arthritis.
Handa R. Handa R. Natl Med J India. 2004 May-Jun;17(3):143-51. Natl Med J India. 2004. PMID: 15253402 Review.
Cited by
- Real-world study comparing the efficacy of Janus kinase inhibitors in patients with difficult-to-treat rheumatoid arthritis.
Hayashi S, Nakano N, Tsubosaka M, Kamenaga T, Kuroda Y, Matsumoto T, Yamada H, Nishimra K, Ueda Y, Saegusa J, Kuroda R. Hayashi S, et al. Clin Rheumatol. 2024 Sep 7. doi: 10.1007/s10067-024-07117-w. Online ahead of print. Clin Rheumatol. 2024. PMID: 39243280 - Diagnostic and Therapeutic Roles of Extracellular Vesicles and Their Enwrapped ncRNAs in Rheumatoid Arthritis.
Liu YR, Wang JQ, Fang L, Xia Q. Liu YR, et al. J Inflamm Res. 2024 Aug 16;17:5475-5494. doi: 10.2147/JIR.S469032. eCollection 2024. J Inflamm Res. 2024. PMID: 39165320 Free PMC article. Review. - Huangqi Guizhi Wuwu Decoction suppresses inflammation and bone destruction in collagen-induced arthritis mice.
Bao J, Song Y, Hang M, Xu H, Li Q, Wang P, Chen T, Xia M, Shi Q, Wang Y, Wang X, Liang Q. Bao J, et al. Chin Herb Med. 2024 Jan 11;16(2):274-281. doi: 10.1016/j.chmed.2023.10.003. eCollection 2024 Apr. Chin Herb Med. 2024. PMID: 38706818 Free PMC article. - A dual dynamically cross-linked hydrogel promotes rheumatoid arthritis repair through ROS initiative regulation and microenvironment modulation-independent triptolide release.
Wang T, Huang C, Fang Z, Bahatibieke A, Fan D, Wang X, Zhao H, Xie Y, Qiao K, Xiao C, Zheng Y. Wang T, et al. Mater Today Bio. 2024 Apr 3;26:101042. doi: 10.1016/j.mtbio.2024.101042. eCollection 2024 Jun. Mater Today Bio. 2024. PMID: 38660473 Free PMC article. - The molecular subtypes of autoimmune diseases.
Cheng X, Meng X, Chen R, Song Z, Li S, Wei S, Lv H, Zhang S, Tang H, Jiang Y, Zhang R. Cheng X, et al. Comput Struct Biotechnol J. 2024 Mar 28;23:1348-1363. doi: 10.1016/j.csbj.2024.03.026. eCollection 2024 Dec. Comput Struct Biotechnol J. 2024. PMID: 38596313 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical